Primary peptide: KPV at 300 to 500 mcg subcutaneously daily (NF-kB suppression in airway epithelium) Support peptide: Ta1 at 1.6 mg subcutaneously twice weekly (immune rebalancing) Duration: 8 to 12 weeks minimum, with reassessment Important note: Peptide protocols for asthma should complement, not replace, prescribed controller medications
Meis, ar Ergin, and Sybren de Hoog One Health Mycology 1: 4-13 (2023)
Recurrence risk for psoriasis and psoriatic arthritis within sibships
Santacroce G, Gentile A, Soriano S, Novelli A, Lenti MV, Di Sabatino A
Over time, these habits change spinal alignment and increase injury risk